London medical concierge is delighted to partner with River Aesthetics, an award-winning cosmetic clinic offering bespoke medical aesthetics, anti-aging treatments and cosmetic procedures. RiverRead More
Being diagnosed with cancer is life-changing for both patients, their families and friends. Even with the very best care in the UK both privately and the NHS, there can still be so many unanswered questions. For example, often treatment plans can change at short notice, or a patient's prognosis is affected by the results of an MRI scan - which opens up discussions around alternative treatment pathways.
Do you want more information about a recent diagnosis, or have questions about your current treatment? Or perhaps you are worried about a friend or partner who is struggling to cope with treatment and are looking for some guidance on where to turn next? If so, we have a unique opportunity for you to put those questions to one of the world's leading cancer specialist - Professor Justin Stebbing.
On Sunday 26th March from 9-10pm, Professor Stebbing will be answering your questions in a Facebook Live event. Simply email your questions in to firstname.lastname@example.org and we'll submit your queries to the Professor.
Introducing Professor Justin Stebbing:
Professor Justin Stebbing MD MA FRCP FRCPath PhD, Professor of Cancer Medicine and Oncology, Consultant Oncologist, Imperial College and Imperial College Healthcare NHS Trust. Professor Stebbing trained in medicine at Trinity College, University of Oxford. After completion of junior doctor posts in Oxford, he undertook training and a residency at The Johns Hopkins Hospital in the US, returning to London to continue his career in oncology at The Royal Marsden and St Bartholomew's Hospital and now through Imperial College Healthcare NHS Trust.
Professor Stebbing has published over 500 peer-reviewed papers in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as writing for national newspapers and presenting new date on optimal cancer therapies at major international conferences.